Basic approaches, challenges and opportunities for the discovery of small molecule anti-tumor drugs

被引：0

作者：

Ma, Yu-Shui ^{[1
,2
,3
]}

Liu, Ji-Bin ^{[2
]}

Yang, Xiao-Li ^{[3
]}

Xin, Rui ^{[3
]}

Shi, Yi ^{[1
,2
]}

Zhang, Dan-Dan ^{[3
]}

Wang, Hui-Min ^{[3
]}

Wang, Pei-Yao ^{[3
]}

Lin, Qin-Lu ^{[1
]}

Li, Wen ^{[1
]}

Fu, Da ^{[1
,3
]}

机构：

[1] Cent South Univ Forestry & Technol, Natl Engn Lab Deep Proc Rice & Byprod, Coll Food Sci & Engn, Changsha 410004, Hunan, Peoples R China

[2] Nantong Tumor Hosp, Canc Inst, Nantong 226631, Peoples R China

[3] Tongji Univ, Shanghai Peoples Hosp 10, Cent Lab Med Res, Sch Med, 36 Yunxin Rd, Shanghai 200072, Peoples R China

来源：

AMERICAN JOURNAL OF CANCER RESEARCH | 2021年 / 11卷 / 06期

基金：

中国国家自然科学基金;

关键词：

Drug therapy; cancer; inhibitor; comprehensive utilization; COLORECTAL-CANCER PROGRESSION; LONG NONCODING RNA; PROMOTES CELL-PROLIFERATION; TARGETED THERAPY; STEM-CELLS; RESISTANCE; EXPRESSION; GENE; OSTEOSARCOMA; ACTIVATION;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Chemotherapy is one of the main treatments for cancer, especially for advanced cancer patients. In the past decade, significant progress has been made with the research into the molecular mechanisms of cancer cells and the precision medicine. The treatment on cancer patients has gradually changed from cytotoxic chemotherapy to precise treatment strategy. Research into anticancer drugs has also changed from killing effects on all cells to targeting drugs for target genes. Besides, researchers have developed the understanding of the abnormal physiological function, related genomics, epigenetics, and proteomics of cancer cells with cancer genome sequencing, epigenetic research, and proteomic research. These technologies and related research have accelerated the development of related cancer drugs. In this review, we summarize the research progress of anticancer drugs, the current challenges, and future opportunities.

引用

页码：2386 / 2400

页数：15

共 50 条

[41] Anti-Tumor Drug Discovery Based on Natural Product β-Elemene: Anti-Tumor Mechanisms and Structural Modification
Bai, Ziqiang
Yao, Chuansheng
Zhu, Junlong
Xie, Yuanyuan
Ye, Xiang-Yang
Bai, Renren
Xie, Tian
MOLECULES, 2021, 26 (06):
[42] Small molecules modulating tumor-stromal cell interactions: new candidates for anti-tumor drugs
Kawada, Manabu
JOURNAL OF ANTIBIOTICS, 2016, 69 (06): : 411 - 414
[43] Fucoidan and Cancer: A Multifunctional Molecule with Anti-Tumor Potential
Atashrazm, Farzaneh
Lowenthal, Ray M.
Woods, Gregory M.
Holloway, Adele F.
Dickinson, Joanne L.
MARINE DRUGS, 2015, 13 (04): : 2327 - 2346
[44] Opportunities and Challenges in the Discovery of New Central Nervous System Drugs
Krause, James E.
Chenard, Bertrand L.
NEURAL SIGNALING: OPPORTUNITIES FOR NOVEL DIAGNOSTIC APPROACHES AND THERAPIES, 2008, 1144 : 243 - 250
[45] DISCOVERY OF CT-179: A SMALL MOLECULE INHIBITOR OF THE OLIG2 TRANSCRIPTION FACTOR WITH POTENT ANTI-TUMOR IN PEDIATRIC BRAIN CANCER
Johns, Terrance
Greenall, Sameer
Chen, Charlotte
Day, Bryan
NEURO-ONCOLOGY, 2018, 20 : 68 - 68
[46] DISCOVERY AND DEVELOPMENT OF ANTI-TUMOR COMPOUNDS FROM FERMENTATION
NEIL, GL
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1977, 174 (SEP): : 38 - 38
[47] DISCOVERY OF ANTI-TUMOR AGENTS FROM NATURAL SOURCES
SUFFNESS, M
DOUROS, JD
TRENDS IN PHARMACOLOGICAL SCIENCES, 1981, 2 (11) : 307 - 310
[48] Potential anti-tumor effect of a small molecule dipeptidyl peptidase inhibitor, 4175, in colorectal cancer
Zhang, Jiping
MacFarlane, Alexander W.
Jones, Barry
Bachovchin, William
Cambpell, Kerry
Borghaei, Hossein
CANCER RESEARCH, 2012, 72
[49] Circulating tumor DNA: Opportunities and challenges for pharmacometric approaches
Ribba, Benjamin
Roller, Andreas
Helms, Hans-Joachim
Stern, Martin
Bleul, Conrad
FRONTIERS IN PHARMACOLOGY, 2023, 13
[50] Predictive Toxicology Approaches for Small Molecule Oncology Drugs
Maziasz, T.
Kadambi, V. J.
Silverman, L.
Fedyk, E.
Alden, C. L.
TOXICOLOGIC PATHOLOGY, 2010, 38 (01) : 148 - 164

← 1 2 3 4 5 →